Inventor
KORTAGERE SANDHYA
US16 patents
⚠️ This page may combine multiple inventors who share the name “KORTAGERE SANDHYA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV DREXEL
12 patentsUS11377452B2Jul 5, 2022
Glutamate transporter activators and methods using same
UNIV DREXEL2 citations67
US11744810B2Sep 5, 2023
Methods of treating or preventing an attention disorder, cognitive disorder, and/or dementia associated with a neurodegenerative disorder
UNIV DREXEL0 citations60
US11266612B2Mar 8, 2022
D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease
UNIV DREXEL0 citations57
US12162891B2Dec 10, 2024
Glutamate transporter activators and methods using same
UNIV DREXEL0 citations56
US11345696B2May 31, 2022
Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same
UNIV DREXEL0 citations53
US10695302B2Jun 30, 2020
Treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder
UNIV DREXEL0 citations50
US9861594B2Jan 9, 2018
Treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder
UNIV DREXEL0 citations50
US10543180B2Jan 28, 2020
D3 dopamine receptor agonists to treat dyskinesia in Parkinson's disease
UNIV DREXEL0 citations47
US10287290B2May 14, 2019
Compositions useful in treating brain-related diseases or disorders and methods using same
UNIV DREXEL0 citations47
US9675565B2Jun 13, 2017
D3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
UNIV DREXEL0 citations47
US9616065B2Apr 11, 2017
Compositions useful in treating brain-related diseases or disorders and methods using same
UNIV DREXEL0 citations45
US10428059B2Oct 1, 2019
Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same
UNIV DREXEL0 citations43